Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals

ABSIBullishCorporate Developmentsnews

High materiality8/10

AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal - MarketWatch

Jan 8, 2025, 8:55 AM EST1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

AMD's significant investment indicates strong confidence in Absci's potential, enhancing market sentiment.

AI summary

What happened, with direct paths to the underlying reporting

AMD invests $20 million in Absci to enhance drug discovery capabilities. Absci's stock surged 54% following AMD's announcement of investment. The partnership aims to leverage AI for faster and cheaper drug development. Traditional drug discovery is costly, with 90% of candidates failing in trials.

AMD invests $20 million in Absci to enhance drug discovery capabilities.
Absci's stock surged 54% following AMD's announcement of investment.
The partnership aims to leverage AI for faster and cheaper drug development.
Traditional drug discovery is costly, with 90% of candidates failing in trials.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal - MarketWatch

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside